Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection (Q47296073)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection |
scientific article |
Statements
1 reference
Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection (English)
1 reference
Suzuki K
1 reference
Miura T
1 reference
Miki T
1 reference
Tsuchida A
1 reference
Shimamoto K
1 reference
1 January 1998
1 reference
31
1 reference
1
1 reference
1-9
1 reference
Identifiers
1 reference